Actively Recruiting
International Ovarian & Testicular Stromal Tumor Registry
Led by Children's Hospitals and Clinics of Minnesota · Updated on 2024-08-22
300
Participants Needed
1
Research Sites
990 weeks
Total Duration
On this page
Sponsors
C
Children's Hospitals and Clinics of Minnesota
Lead Sponsor
C
Children's National Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
Rare tumors are understudied, yet have the potential to shed light on vast areas of cancer research. Ovarian sex cord-stromal tumors, rare tumors of childhood and young adulthood, have recently been found to be associated with a lung cancer of early childhood called pleuropulmonary blastoma (PPB). The cause of these ovarian tumors is unknown. DICER1 mutations are seen in the majority of children with PPB. Research shows DICER1 mutations are also seen in some patients with ovarian tumors. Like PPB, ovarian stromal tumors are highly curable when found in early stage; however, later forms of the disease are aggressive and often fatal. The International Ovarian Stromal Tumor Registry collects clinical and biologic data to understand why these tumors occur and how to treat them. Current work involves the study of the role of DICER1 and miRNA expression in ovarian stromal tumors. Understanding the clinical history, predisposing factors and DICER1 and miRNA expression in these ovarian tumors of childhood will lead to targeted screening and risk stratification for evidence-based treatment and biologically rational therapies. These efforts will improve the lives of children by increasing survival and reducing late effects. The specific goals of the International Ovarian and Testicular Stromal Tumor Registry are: 1. to understand risk factors by studying age, pathologic subtype, histopathologic features, tumor invasiveness, degree of differentiation, presence of metastasis 2. to collect information on personal and family history in order to refine the clinical characteristics of patients and families with and without germline DICER1 mutations and other genetic predisposing factors 3. to determine whether there is a pattern of gene expression or DNA alterations that correlate with predisposition to ovarian tumors, biologic behavior and clinical outcome 4. to determine optimal screening regimens 5. to use clinical data obtained through the Registry to refine treatment algorithms 6. to establish a collection of annotated biology specimens (tumor tissue and germline DNA) for future research
CONDITIONS
Official Title
International Ovarian & Testicular Stromal Tumor Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Previous or current diagnosis of an ovarian sex cord stromal tumor including but not limited to Sertoli-Leydig cell tumor, gynandroblastoma, juvenile granulosa cell tumor, Sertoli cell tumor, sex cord-stromal tumor with annular tubules, or undifferentiated stromal tumor
- Previous or current diagnosis of a testicular stromal tumor including but not limited to juvenile granulosa cell tumor, Sertoli cell tumor, Leydig cell tumor, or undifferentiated stromal tumor
You will not qualify if you...
- Unable to provide informed consent or assent
- Adult granulosa cell tumor (unless otherwise specified by Medical Director)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's Minnesota
Minneapolis, Minnesota, United States, 55404
Actively Recruiting
Research Team
A
Anne Harris, MPH
CONTACT
P
Paige Mallinger, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here